Anika Therapeutics (ANIK) Financials: Revenue & Earnings

ANIK price $21.26 -0.09 -0.41%

Ticker
ANIK
Price
$21.26
Change
-0.09 -0.41%
Market cap ?
$284.57M
P/E ?
-79.48
Forward P/E ?
20.25
Dividend yield ?
0.00%
Beta ?
0.21
Sector
Healthcare
Industry
Medical - Specialties
Stocklytics score
40
Value
28
Quality
35
Growth
58

Stocklytics score rationale: value 28, quality 35, growth 58.

Financials

2016201720182019202020212022202320242025
103379000113420000105555000114610000130457000147794000113827000120792000119907000112819000

Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core focus areas include osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and advanced bone-preserving joint technologies. All of Anika's products are developed, manufactured, and…

Fair value

ANIK fair value $21.99. Price $21.26. Price is about fair value.

Below fair value, around its usual discount.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Compare ANIK

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-06—0.42—29.44M
2026-07-290.420.0332.61M29.21M
2026-04-290.27-0.0729.61M28.14M
2026-02-260.31-0.1230.61M28.88M
2025-11-050.040.0227.82M27.80M
2025-07-30-0.13-0.1328.22M27.53M
2025-05-09-0.060.0926.17M28.07M
2025-03-12-0.03-0.01-1.29M28.12M
2024-10-31-0.250.3038.75M29.00M
2024-08-080.170.2341.92M42.10M
2024-05-08-0.31-0.1940.52M39.21M
2024-03-13-4.30-0.2642.97M41.40M
2023-11-02-0.45-0.3341.47M41.40M
2023-08-08-0.19-0.3444.30M40.56M
2023-05-09-0.71-0.3037.92M37.36M
2023-03-06-0.34-0.2239.62M37.71M
2022-11-08-0.29-0.2440.26M37.59M
2022-08-03-0.20-0.2639.66M37.85M
2022-05-05-0.20-0.3136.69M32.93M
2022-03-08-0.40-0.2535.82M32.05M
2021-11-040.04-0.2139.54M36.65M
2021-08-050.45-0.1538.15M35.40M
2021-05-060.20-0.1234.29M113.16M
2021-03-04-1.10-0.1032.69M—
2020-11-04-0.45-0.0831.69M704.31K
2020-07-300.09-0.2130.68M28.47M
2020-05-070.450.4035.40M5.31M
2020-02-200.430.4129.77M44.66M
2019-10-240.640.3929.70M26.38M
2019-07-240.680.3930.42M28.96M
2019-05-020.310.1924.72M15.15M
2019-02-210.540.3326.96M16.47M
2018-10-240.530.3126.79M19.25M
2018-07-250.680.3330.55M23.20M
2018-05-020.110.2521.26M7.40M
2018-02-210.380.4129.39M34.03M
2017-10-250.460.4527.18M26.59M
2017-07-260.760.4433.46M22.59M
2017-05-030.370.3823.39M24.02M
2017-02-150.540.5328.73M28.19M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-04Fischetti Gary PBuy1.00K$20.3220.32K
2026-08-03Fischetti Gary PBuy1.00K$20.7520.75K
2026-06-18Fischetti Gary PBuy10.40K——
2026-06-18HENNEMAN JOHN B IIIBuy10.40K——
2026-06-18Richard StephenBuy10.40K——
2026-06-18Capper Joseph HBuy10.40K——
2026-06-18CONLEY SHERYL LBuy10.40K——
2026-06-03Griffin Stephen D.Buy12.84K——
2026-06-03Griffin Stephen D.Sell3.77K$14.4154.31K
2026-06-03Griffin Stephen D.Sell12.84K——
2026-05-01HENNEMAN JOHN B IIIBuy5.00K$14.6673.32K
2026-04-30Griffin Stephen D.Buy12.20K$12.29149.88K
2026-03-19McLeod IanBuy17.66K$15.60275.54K
2026-03-19McLeod IanBuy13.10K——
2026-03-19McLeod IanBuy11.19K——
2026-03-15Colleran DavidBuy6.45K——
2026-03-15Colleran DavidSell1.89K$14.2026.88K
2026-03-15Colleran DavidSell6.45K——
2026-03-15Blanchard Cheryl RBuy25.13K——
2026-03-15Blanchard Cheryl RSell12.10K$14.20171.88K
2026-03-15Blanchard Cheryl RSell25.13K——
2026-03-15McLeod IanBuy2.66K——
2026-03-15McLeod IanSell781$14.2011.09K
2026-03-15McLeod IanSell2.66K——
2026-03-14Colleran DavidBuy4.69K——
2026-03-14Colleran DavidSell4.17K$14.2059.19K
2026-03-14Colleran DavidBuy9.39K——
2026-03-14Colleran DavidSell9.39K——
2026-03-14Griffin Stephen D.Buy6.41K——
2026-03-14Griffin Stephen D.Sell12.82K——
2026-03-14Griffin Stephen D.Sell5.94K$14.2084.40K
2026-03-14Griffin Stephen D.Buy12.82K——
2026-03-14Blanchard Cheryl RBuy24.52K——
2026-03-14Blanchard Cheryl RSell14.73K$14.20209.14K
2026-03-14Blanchard Cheryl RBuy24.52K——
2026-03-14Blanchard Cheryl RSell24.52K——
2026-03-14McLeod IanBuy1.16K——
2026-03-14McLeod IanBuy3.77K——
2026-03-14McLeod IanSell1.45K$14.2020.58K
2026-03-14McLeod IanSell3.77K——
2026-02-01Griffin Stephen D.Buy310.21K$9.232.86M
2026-02-01Griffin Stephen D.Buy130.40K——
2025-06-20VOGT SUSAN L NBuy14.16K——
2025-06-20Richard StephenBuy14.16K——
2025-06-20Larsen Glenn R.Buy14.16K——
2025-06-20Jellison William RBuy14.16K——
2025-06-20HENNEMAN JOHN B IIIBuy14.16K——
2025-06-20Fischetti Gary PBuy14.16K——
2025-06-20CONLEY SHERYL LBuy14.16K——
2025-06-20Capper Joseph HBuy14.16K——
2025-06-03Griffin Stephen D.Buy12.84K——
2025-06-03Griffin Stephen D.Buy12.84K——
2025-06-03Griffin Stephen D.Sell3.77K$11.5943.68K
2025-04-05McLeod IanOther0——
2025-04-05McLeod IanOther6.35K$27.98177.56K
2025-04-05McLeod IanOther2.54K——
2025-04-05McLeod IanOther2.36K$29.6069.92K
2025-03-17Nunes AnneBuy3.64K——
2025-03-17Nunes AnneSell1.07K$15.9116.99K
2025-03-17Nunes AnneSell3.64K——
2025-03-17Colleran DavidBuy6.45K——
2025-03-17Colleran DavidSell1.89K$15.9130.12K
2025-03-17Colleran DavidSell6.45K——
2025-03-17Blanchard Cheryl RBuy25.13K——
2025-03-17Blanchard Cheryl RSell12.15K$15.91193.34K
2025-03-17Blanchard Cheryl RSell25.13K——
2025-03-14Nunes AnneBuy20.76K——
2025-03-14Nunes AnneBuy4.65K——
2025-03-14Griffin Stephen D.Buy38.47K——
2025-03-14Griffin Stephen D.Buy18.67K——
2025-03-14Colleran DavidBuy28.16K——
2025-03-14Colleran DavidBuy13.67K——
2025-03-14Blanchard Cheryl RBuy73.56K——
2025-03-14Blanchard Cheryl RBuy71.40K——
2025-03-11Nunes AnneBuy2.56K——
2025-03-11Nunes AnneSell752$16.7912.63K
2025-03-11Nunes AnneSell2.56K——
2025-03-11Colleran DavidBuy7.66K——
2025-03-11Colleran DavidSell2.25K$16.7937.78K
2025-03-11Colleran DavidSell7.66K——
2025-03-11Blanchard Cheryl RBuy30.06K——
2025-03-11Blanchard Cheryl RSell12.68K$16.79212.81K
2025-03-11Blanchard Cheryl RSell30.06K——
2025-03-10Nunes AnneBuy3.30K——
2025-03-10Nunes AnneSell959$16.6215.94K
2025-03-10Nunes AnneSell3.30K——
2025-03-10Colleran DavidBuy5.46K——
2025-03-10Colleran DavidSell1.60K$16.6226.66K
2025-03-10Colleran DavidSell5.46K——
2025-03-10Blanchard Cheryl RBuy20.00K——
2025-03-10Blanchard Cheryl RSell5.87K$16.6297.58K
2025-03-10Blanchard Cheryl RSell20.00K——
2024-10-01Nunes AnneBuy2.49K——
2024-10-01Nunes AnneSell732$24.2717.77K
2024-10-01Nunes AnneSell2.49K——
2024-07-09VOGT SUSAN L NBuy5.77K——
2024-07-09Richard StephenBuy5.77K——
2024-07-09Larsen Glenn R.Buy5.77K——
2024-07-09Jellison William RBuy5.77K——
2024-07-09HENNEMAN JOHN B IIIBuy5.77K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 135, holders +4 vs prior quarter. Ownership 91.28%.

HolderSharesChangeChange %Value
BLACKROCK, INC.1.45M-145.22K-9.11%21.21M
CALIGAN PARTNERS LP1.44M00.00%21.00M
MORGAN STANLEY614.32K-257.75K-29.56%8.99M
ACADIAN ASSET MANAGEMENT LLC606.54K00.00%8.87M
VANGUARD CAPITAL MANAGEMENT LLC572.11K-33.66K-5.56%8.37M
AQR CAPITAL MANAGEMENT LLC559.85K287.58K+105.62%8.19M
BOOTHBAY FUND MANAGEMENT, LLC529.64K137+0.03%7.75M
RENAISSANCE TECHNOLOGIES LLC481.42K-20.80K-4.14%7.04M
DIMENSIONAL FUND ADVISORS LP451.10K-7.75K-1.69%6.60M
CAPITAL MANAGEMENT CORP /VA448.47K753+0.17%6.56M
DEUTSCHE BANK AG\353.55K378+0.11%5.17M
GEODE CAPITAL MANAGEMENT, LLC331.58K1.53K+0.46%4.85M
STATE STREET CORP311.90K-34.20K-9.88%4.56M
TWO SIGMA INVESTMENTS, LP252.96K16.84K+7.13%3.70M
D. E. SHAW & CO., INC.245.07K15.27K+6.65%3.59M
GOLDMAN SACHS GROUP INC237.72K19.84K+9.11%3.48M
JACOBS LEVY EQUITY MANAGEMENT, INC217.53K-48.10K-18.11%3.18M
NUVEEN, LLC156.54K35.82K+29.67%2.29M
QUANTINNO CAPITAL MANAGEMENT LP155.26K29.43K+23.39%2.27M
UBS GROUP AG145.82K12.74K+9.58%2.13M
MAN GROUP PLC140.71K16.42K+13.21%2.06M
HILLSDALE INVESTMENT MANAGEMENT INC.138.82K113.42K+446.54%2.03M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.113.37K113.37KNew1.66M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC113.37K-1.02K-0.90%1.66M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP106.64K75.29K+240.13%1.56M

Earnings and financials

Anika Therapeutics, Inc. (ANIK) trades at $21.26, with a market cap of $284.57M and a trailing P/E of -79.48. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
103379000113420000105555000114610000130457000147794000113827000120792000119907000112819000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Anika Therapeutics (ANIK) Financials: Revenue & Earnings

ANIK$21.26-0.09 -0.41%

$284.57M

Market Cap

-79.48

P/E

20.25

Forward P/E

40

Score

Price History